SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/160531"
 

Search: onr:"swepub:oai:gup.ub.gu.se/160531" > Overall and cause-s...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003836naa a2200505 4500
001oai:gup.ub.gu.se/160531
003SwePub
008240528s2012 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/1605312 URI
024a https://doi.org/10.1530/eje-11-10282 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Gaillard, R. C.4 aut
2451 0a Overall and cause-specific mortality in GH-deficient adults on GH replacement
264 1b Oxford University Press (OUP),c 2012
520 a Objective: Hypopituitarism is associated with an increased mortality rate but the reasons underlying this have not been fully elucidated. The purpose of this study was to evaluate mortality and associated factors within a large GH-replaced population of hypopituitary patients. Design: In KIMS (Pfizer International Metabolic Database) 13 983 GH-deficient patients with 69 056 patient-years of follow-up were available. Methods: This study analysed standardised mortality ratios (SMRs) by Poisson regression. IGF1 SDS was used as an indicator of adequacy of GH replacement. Statistical significance was set to P<0.05. Results: All-cause mortality was 13% higher compared with normal population rates (SMR, 1.13; 95% confidence interval, 1.04-1.24). Significant associations were female gender, younger age at follow-up, underlying diagnosis of Cushing's disease, craniopharyngioma and aggressive tumour and presence of diabetes insipidus. After controlling for confounding factors, there were statistically significant negative associations between IGF1 SDS after 1, 2 and 3 years of GH replacement and SMR. For cause-specific mortality there was a negative association between 1-year IGF1 SDS and SMR for deaths from cardiovascular diseases (P=0.017) and malignancies (P=0.044). Conclusions: GH-replaced patients with hypopituitarism demonstrated a modest increase in mortality rate; this appears lower than that previously published in GH-deficient patients. Factors associated with increased mortality included female gender, younger attained age, aetiology and lower IGF1 SDS during therapy. These data indicate that GH replacement in hypopituitary adults with GH deficiency may be considered a safe treatment.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng
653 a growth-hormone deficiency
653 a hypopituitary adults
653 a premature mortality
653 a cardiovascular risk
653 a pituitary-adenoma
653 a disease
653 a therapy
653 a association
653 a life
700a Mattsson, A. F.4 aut
700a Akerblad, A. C.4 aut
700a Bengtsson, Bengt-Åke,d 1944u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för invärtesmedicin och klinisk nutrition,Institute of Medicine, Department of Internal Medicine and Clinical Nutrition4 aut0 (Swepub:gu)xbenbe
700a Cara, J.4 aut
700a Feldt-Rasmussen, U.4 aut
700a Koltowska-Haggstrom, M.4 aut
700a Monson, J. P.4 aut
700a Saller, B.4 aut
700a Wilton, P.4 aut
700a Abs, R.4 aut
710a Göteborgs universitetb Institutionen för medicin, avdelningen för invärtesmedicin och klinisk nutrition4 org
773t European Journal of Endocrinologyd : Oxford University Press (OUP)g 166:6, s. 1069-1077q 166:6<1069-1077x 0804-4643x 1479-683X
856u https://eje.bioscientifica.com/downloadpdf/journals/eje/166/6/1069.pdf
8564 8u https://gup.ub.gu.se/publication/160531
8564 8u https://doi.org/10.1530/eje-11-1028

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view